Friday, July 31, 2026

Imjin River Water Level Tops 3 Meters as North Korea’s Hwanggang Dam Suspected of Releasing Water

Water levels at Pilsung Bridge have surpassed 3 meters due to North Korea's water discharge, prompting evacuation measures and safety warnings.

Galaxy S26 Ultra: The Best Smartphone in Europe – What Makes It Stand Out?

Samsung's Galaxy S26 Ultra tops smartphone evaluations in Europe, praised for performance, camera, and battery life by multiple consumer groups.

iPhone Icons Are Getting a Total Makeover in iOS 26

iOS 26 revamps iPhone icons with new customization options, including Clear Mode and improved Dark mode, enhancing user experience.

Tag: cancer

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Revolutionary Immune Therapy for Colon Cancer: How MAFB Protein Manipulation Enhances Treatment Response

Korea University researchers have developed a new colorectal cancer treatment strategy by regulating tumor-associated macrophages to enhance immune response.

How Penetrium’s Innovative Approach Could Change Cancer Treatment Forever

Penetrium Bioscience will unveil a new therapeutic mechanism for treating cancer and other diseases on April 16 in Seoul.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

Proton Therapy for Liver Cancer: Revolutionary Results from Samsung Medical Center

Samsung Medical Center's proton therapy shows high effectiveness for liver cancer, offering hope for patients unsuitable for standard treatments.

FDA Grants Orphan Drug Status to Tovecimig: What This Means for Cholangiocarcinoma Treatment

ABL Bio's Tovecimig receives Orphan Drug Designation from the FDA, enhancing its approval prospects for cholangiocarcinoma treatment.

CT-P71: The New ADC Cancer Drug Fast-Tracked by FDA for Urothelial Carcinoma

Celltrion's CT-P71 receives FDA Fast Track designation for urothelial carcinoma, enhancing its ADC pipeline and global drug development efforts.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

2026 Hyundai Boulder: The Ultimate Off-Road Pickup Truck Concept Revealed!

Hyundai unveils the Boulder, an off-road concept vehicle, at the NY Auto Show, showcasing its commitment to U.S. mid-size pickup market.

Samsung Medical Center Achieves ICHOM Certification: A New Era for Patient-Centered Cancer Care in Korea

Samsung Medical Center's Cancer Hospital is the first in South Korea to receive ICHOM certification for patient-centered care in breast cancer.

Alpha Tau Medical’s Alpha DaRT: A New Hope for Pancreatic Cancer Patients – What You Need to Know

Alpha Tau Medical will present clinical results of its DaRT technology for pancreatic cancer at DDW 2026, marking a significant milestone.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

Daejeon University’s Seoul Oriental Hospital Earns “Integrated Cancer Certification” – What This Means for Patients

Daejeon University's Seoul Oriental Hospital gains recognition as a Certified Integrative Cancer Center for its innovative treatment methods.

Top News

- Our Sponsors Ad -

Follow us